Mimedx Group Inc MDXG Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$3.35 up $0.07, 1.98% on Nov 6
Last price · Previous close $3.28
- Market cap
- At the last price
- P/E ratio
- On last 12 months’ EPS
- Diluted EPS
- Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$3.35up $0.07, 1.98%Fri, Nov 6 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$3.28Nov 5
- Volume2.83MNov 5 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume1.80MLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $3.03 to $7.77; now $3.35
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the last price. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
MDXG trailed the S&P 500 in all 7 periods.
| Period | MDXG and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | MDXG: down 27.6% S&P 500: down 5.6% | MDXG trailed the S&P 500 by 22.0 percentage points Trailed |
| 3M | MDXG: down 20.0% S&P 500: down 4.1% | MDXG trailed the S&P 500 by 15.9 percentage points Trailed |
| YTD | MDXG: down 50.6% S&P 500: up 8.7% | MDXG trailed the S&P 500 by 59.3 percentage points Trailed |
| 1Y | MDXG: down 54.4% S&P 500: up 10.9% | MDXG trailed the S&P 500 by 65.3 percentage points Trailed |
| Long term | ||
| 3Y | MDXG: down 50.0% S&P 500: up 75.0% −20.6% vs +20.5% a year | MDXG trailed the S&P 500 by 125.0 percentage points Trailed |
| 5Y | MDXG: down 59.9% S&P 500: up 67.8% −16.7% vs +10.9% a year | MDXG trailed the S&P 500 by 127.7 percentage points Trailed |
| 10Y | MDXG: down 58.7% S&P 500: up 313.1% −8.5% vs +15.2% a year | MDXG trailed the S&P 500 by 371.8 percentage points Trailed |
$10,000 invested in MDXG 10 years ago (Nov 4, 2016) would be worth about $4,130 as of , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,313.
MDXG trailed the S&P 500 in all 7 periods.
| Period | MDXG and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | MDXG: down 27.6% S&P 500: down 5.6% | MDXG trailed the S&P 500 by 22.0 percentage points Trailed |
| 3M | MDXG: down 20.0% S&P 500: down 4.3% | MDXG trailed the S&P 500 by 15.7 percentage points Trailed |
| YTD | MDXG: down 50.6% S&P 500: up 7.8% | MDXG trailed the S&P 500 by 58.4 percentage points Trailed |
| 1Y | MDXG: down 54.4% S&P 500: up 9.7% | MDXG trailed the S&P 500 by 64.1 percentage points Trailed |
| Long term | ||
| 3Y | MDXG: down 50.0% S&P 500: up 68.8% −20.6% vs +19.1% a year | MDXG trailed the S&P 500 by 118.8 percentage points Trailed |
| 5Y | MDXG: down 59.9% S&P 500: up 56.9% −16.7% vs +9.4% a year | MDXG trailed the S&P 500 by 116.8 percentage points Trailed |
| 10Y | MDXG: down 58.7% S&P 500: up 252.6% −8.5% vs +13.4% a year | MDXG trailed the S&P 500 by 311.3 percentage points Trailed |
$10,000 invested in MDXG 10 years ago (Nov 4, 2016) would be worth about $4,130 as of , not counting dividends. The same amount in the S&P 500 would be worth about $35,257.
All-time high
$17.96
Closing high on . Now 81.4% below that record.
Split-adjusted daily closes since Aug 22, 2007.
Stock splits
1
9-for-28 on . Share counts adjust after each split.
Valuation
Financials
About Mimedx Group Inc
MiMedx is an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental biologics, we have both a core business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. We derive our products from human placental tissues and process these tissues using our proprietary methods, including the PURION ® process. We employ Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce our allografts. MiMedx has supplied over two million allografts, through both direct and consignment shipments.
- Sector
- Industry
- Headquarters
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
MDXG news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
MDXG stock FAQ
What is MDXG stock’s price today?
Mimedx Group (MDXG) traded at $3.35 as of , up $0.07 (1.98%) from the previous close of $3.28. Over the past 52 weeks it has traded between $3.03 and $7.77.
If you invested $1,000 in MDXG 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in MDXG on would be worth about $413 as of , a total return of −58.7%. The same $1,000 would be worth $401 if invested five years ago and $456 if invested one year ago. Past performance doesn’t predict future returns.
Does MDXG pay a dividend?
Mimedx Group hasn’t paid a dividend in the last twelve months.
What is MDXG’s 52-week high and low?
Over the past 52 weeks MDXG has traded as low as $3.03 and as high as $7.77. At $3.35 as of , it is 56.9% below that high and 10.6% above the low.
What is MDXG’s all-time high?
MDXG’s highest closing price was $17.96 on , adjusted for stock splits. At $3.35 as of , it is 81.4% below that record.
Has MDXG stock ever split?
Yes, once: 9-for-28 on .
How has MDXG stock performed?
Including dividends and measured to the last price on , MDXG has returned −50.6% so far this year and −54.4% over the past year, and −59.9% over five years (−16.7% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.
What exchange does MDXG trade on?
Mimedx Group trades on the Nasdaq under the ticker symbol MDXG. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.